Robert Thomas Dechant, chief executive officer and a director of IBEX Ltd (NASDAQ:IBEX), sold 5,000 common shares of the company on November 9, 2026, according to a regulatory filing. The transactions totaled $250,031, with shares changing hands at prices between $50.00 and $50.14. The sale was conducted pursuant to a pre-arranged 10b5-1 trading plan that Dechant established on November 18, 2025.
Following the sale, Dechant directly owns 297,448 common shares of IBEX Ltd. The transaction occurred as the stock was trading at $52.23, just below its 52-week high of $52.29, after a notable 16.85% gain over the past week. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value.
The insider sale comes on the heels of IBEX’s impressive fiscal first-quarter results, which exceeded expectations. The company reported adjusted earnings per share of $1.10, surpassing the forecasted $0.93. Additionally, IBEX achieved record revenue of $175.2 million, above the estimated $168.93 million, marking a 16% increase from the previous year. In light of these strong results, IBEX has raised its full-year outlook.
These developments highlight the company’s robust performance and strategic advancements. Investors and analysts are closely monitoring IBEX’s continued growth trajectory.
Investors seeking further insight into IBEX’s financial health and growth prospects can access 12 additional InvestingPro Tips about the company.